Page last updated: 2024-11-05
trifluoperazine and Weight Gain
trifluoperazine has been researched along with Weight Gain in 1 studies
Weight Gain: Increase in BODY WEIGHT over existing weight.
Research Excerpts
| Excerpt | Relevance | Reference |
|---|
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|
| Kroeze, WK | 1 |
| Hufeisen, SJ | 1 |
| Popadak, BA | 1 |
| Renock, SM | 1 |
| Steinberg, S | 1 |
| Ernsberger, P | 1 |
| Jayathilake, K | 1 |
| Meltzer, HY | 1 |
| Roth, BL | 1 |
Clinical Trials (1)
Trial Overview
| Trial | Phase | Enrollment | Study Type | Start Date | Status |
|---|
| Orally-Disintegrating vs. Regular Olanzapine Tablets: Effects on Weight and GI Hormones[NCT00384332] | Phase 4 | 20 participants (Actual) | Interventional | 2007-01-31 | Completed |
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Trial Outcomes
Change From Baseline Montgomery Asberg Depression Rating Scale
Montgomery Asberg Depression Rating Scale (MADRS) total score. Construct: Depression severity. Scores below represent mean change scores, endpoint minus baseline. Minimum total score: 0 (no depression). Maximum total score: 60 (severe depression). Lower (more negative) scores indicate a better outcome. There are no subscales. (NCT00384332)
Timeframe: 10 weeks
| Intervention | units on a scale (Mean) |
|---|
| Arm 1 | -15.5 |
| Arm 2 | -15.5 |
Weight in Kilograms at Baseline, Weeks 1, 4, 6, and 8
Change in weight from baseline to endpoint in kilograms. Reported as weight in Kilograms at Baseline, Weeks 1, 4, 6, and 8 (NCT00384332)
Timeframe: 10 weeks
| Intervention | kilograms (Mean) |
|---|
| Baseline | Week 1 | Week 4 | Week 6 | Week 8 |
|---|
| Arm 1- ODT | 76.0 | 77.4 | 77.8 | 78.9 | 79.1 |
,| Arm 2- SOT | 76.1 | 77.6 | 78.3 | 79.4 | 80.1 |
Other Studies
1 other study available for trifluoperazine and Weight Gain